Vaccines: Major Conference Sept. 5-8 in Philadelphia.AIDS Vaccine AIDS vaccine A hypothetical vaccine intended to either prevent HIV infection or ensure that those infected will not fall victim to AIDS; the most promising vaccine is that using a naked DNA plasmid, reported by Letwin et al in 20/10/00 Science; as of early 2001, 2001, a major scientific conference on AIDS vaccine development, will take place September 5-8 at the Philadelphia Marriott. Sponsors include the U.S. National Institutes of Health, U.S. Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), agency of the U.S. Public Health Service since 1973, with headquarters in Atlanta; it was established in 1946 as the Communicable Disease Center. , UNAIDS UNAIDS Joint United Nations Programme on HIV/AIDS , the World Health Organization, and the Agence Nationale de Recherches sur le SIDA, in France. The organizing committee is David L. Baltimore, Ph.D., Beatrice H. Hahn, M.D., Norman L. Letvin, M.D., Douglas D. Richman, M.D., and Melissa Sordyl. The program committee includes scientists from China, France, India, Kenya, South Africa South Africa, Afrikaans Suid-Afrika, officially Republic of South Africa, republic (2005 est. pop. 44,344,000), 471,442 sq mi (1,221,037 sq km), S Africa. , Uganda, and UK, as well as the U.S. The advance registration deadline has recently been extended to August 17. After that, persons should register onsite at the Philadelphia Marriott. International press note: "Representatives from non-U.S. media are required to pre-register by Friday, August 24, 2001 in order to receive press credentials to attend the AIDS Vaccine 2001 conference. On-site media registration is not available for non-U.S. media due to the need to verify media credentials in advance" (quoted from the conference Web site, August 5). This has been a problem in at least one previous AIDS conference, as reporters are not used to registering in advance to cover news, and will often not learn of the requirement in time. We are concerned that international journalists may be turned away. Program The conference has more than 60 sessions. Talks include: * The Global Need for an AIDS Vaccine (keynote talk in opening session) * Lessons from Acute Infection and Relevance to Vaccine Development * Innate Immunity innate immunity n. Immunity that occurs naturally as a result of a person's genetic constitution or physiology and does not arise from a previous infection or vaccination. * Candidate Vaccines * Access and Implementation * Novel Envelope Immunogens * Experience with AIDS Clinical Trials in Humans: What We've Learned * Design, Oversight, and Review of Phase III Efficacy Trials * Therapeutic Vaccines and Immune Response immune response n. An integrated bodily response to an antigen, especially one mediated by lymphocytes and involving recognition of antigens by specific antibodies or previously sensitized lymphocytes. * The Genesis of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. Diversity * Late Breaker and Innovative Strategies Session In addition there are many poster sessions, mostly on technical topics. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion